CD47 antibody (20305-1-AP) | Proteintech
CD47 antibody (66304-1-Ig) | Proteintech
Recombinant human CD47 protein (Active) (ab174029) | Abcam
Recombinant Human CD47 protein (ABIN7457998)
Anti-CD47 antibody (ab214453) | Abcam
![Anti-CD47 antibody [CD47/2937] (ab260418) | Abcam](https://www.abcam.com/ps/products/260/ab260418/Images/ab260418-353265-anti-cd47-antibody-cd47-2937-immunohistochemistry-prostate-carcinoma-human-1.jpg "Anti-CD47 antibody [CD47/2937] (ab260418) | Abcam")
Anti-CD47 antibody [CD47/2937] (ab260418) | Abcam
CD47 antibody (66304-1-Ig) | Proteintech
CD47 (D3O7P) Rabbit mAb | Cell Signaling Technology
![Anti-CD47 antibody [OX-101] (ab33852) | Abcam](https://www.abcam.com/ps/products/33/ab33852/Images/ab33852-1-ab33852Flow1.jpg "Anti-CD47 antibody [OX-101] (ab33852) | Abcam")
Anti-CD47 antibody [OX-101] (ab33852) | Abcam
CD47 (D3O7P) Rabbit mAb (BSA and Azide Free) | Cell Signaling Technology
Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Tr
CD47/SIRPα axis: bridging innate and adaptive immunity | Journal for ImmunoTherapy of Cancer
Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity | Journal for ImmunoTherapy of Cancer
Recombinant Human CD47 protein (ABIN2870532)
Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity | Journal for ImmunoTherapy of Cancer
Best high school girls basketball team in all 50 states - CBSSports.com
![Recombinant Anti-CD47 antibody [EPR24922-21] KO Tested (ab300124) | Abcam](https://www.abcam.com/ps/products/300/ab300124/Images/AB300124-485968-WB1.jpg "Recombinant Anti-CD47 antibody [EPR24922-21] KO Tested (ab300124) | Abcam")
Recombinant Anti-CD47 antibody [EPR24922-21] KO Tested (ab300124) | Abcam
Recombinant Human CD47 protein (ABIN6961081)
Recombinant Human CD47 protein (ABIN7457998)
CD47 (D3O7P) Rabbit mAb | Cell Signaling Technology
Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity | Journal for ImmunoTherapy of Cancer
CD47 antibody (20305-1-AP) | Proteintech
